These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16464590)

  • 1. Radanamycin, a macrocyclic chimera of radicicol and geldanamycin.
    Wang M; Shen G; Blagg BS
    Bioorg Med Chem Lett; 2006 May; 16(9):2459-62. PubMed ID: 16464590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and evaluation of a radicicol and geldanamycin chimera, radamide.
    Clevenger RC; Blagg BS
    Org Lett; 2004 Nov; 6(24):4459-62. PubMed ID: 15548050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radester, a novel inhibitor of the Hsp90 protein folding machinery.
    Shen G; Blagg BS
    Org Lett; 2005 May; 7(11):2157-60. PubMed ID: 15901158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and structure--activity relationships for chimeric inhibitors of Hsp90.
    Shen G; Wang M; Welch TR; Blagg BS
    J Org Chem; 2006 Sep; 71(20):7618-31. PubMed ID: 16995666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.
    Roe SM; Prodromou C; O'Brien R; Ladbury JE; Piper PW; Pearl LH
    J Med Chem; 1999 Jan; 42(2):260-6. PubMed ID: 9925731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling molecules.
    Soga S; Neckers LM; Schulte TW; Shiotsu Y; Akasaka K; Narumi H; Agatsuma T; Ikuina Y; Murakata C; Tamaoki T; Akinaga S
    Cancer Res; 1999 Jun; 59(12):2931-8. PubMed ID: 10383157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geldanamycin, radicicol, and chimeric inhibitors of the Hsp90 N-terminal ATP binding site.
    Hadden MK; Lubbers DJ; Blagg BS
    Curr Top Med Chem; 2006; 6(11):1173-82. PubMed ID: 16842154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of a new class of geldanamycin derivatives as potent inhibitors of Hsp90.
    Le Brazidec JY; Kamal A; Busch D; Thao L; Zhang L; Timony G; Grecko R; Trent K; Lough R; Salazar T; Khan S; Burrows F; Boehm MF
    J Med Chem; 2004 Jul; 47(15):3865-73. PubMed ID: 15239664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Learning from nature: advances in geldanamycin- and radicicol-based inhibitors of Hsp90.
    Kitson RR; Moody CJ
    J Org Chem; 2013 Jun; 78(11):5117-41. PubMed ID: 23496136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic radicicol binds to the N-terminal domain of Hsp90 and shares important biologic activities with geldanamycin.
    Schulte TW; Akinaga S; Soga S; Sullivan W; Stensgard B; Toft D; Neckers LM
    Cell Stress Chaperones; 1998 Jun; 3(2):100-8. PubMed ID: 9672245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radicicol but not geldanamycin evokes oxidative stress response and efflux protein inhibition in ARPE-19 human retinal pigment epithelial cells.
    Ryhänen T; Mannermaa E; Oksala N; Viiri J; Paimela T; Salminen A; Atalay M; Kaarniranta K
    Eur J Pharmacol; 2008 Apr; 584(2-3):229-36. PubMed ID: 18313664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of radamide analogues, a chimera of radicicol and geldanamycin.
    Hadden MK; Blagg BS
    J Org Chem; 2009 Jul; 74(13):4697-704. PubMed ID: 19492825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of archaeal growth and DNA topoisomerase VI activities by the Hsp90 inhibitor radicicol.
    Gadelle D; Bocs C; Graille M; Forterre P
    Nucleic Acids Res; 2005; 33(7):2310-7. PubMed ID: 15849317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a macrocyclic o-aminobenzamide Hsp90 inhibitor with heterocyclic tether that shows extended biomarker activity and in vivo efficacy in a mouse xenograft model.
    Zapf CW; Bloom JD; McBean JL; Dushin RG; Golas JM; Liu H; Lucas J; Boschelli F; Vogan E; Levin JI
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3627-31. PubMed ID: 21605975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hsp90 is required for heme binding and activation of apo-neuronal nitric-oxide synthase: geldanamycin-mediated oxidant generation is unrelated to any action of hsp90.
    Billecke SS; Bender AT; Kanelakis KC; Murphy PJ; Lowe ER; Kamada Y; Pratt WB; Osawa Y
    J Biol Chem; 2002 Jun; 277(23):20504-9. PubMed ID: 11923316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of radicicol with members of the heat shock protein 90 family of molecular chaperones.
    Schulte TW; Akinaga S; Murakata T; Agatsuma T; Sugimoto S; Nakano H; Lee YS; Simen BB; Argon Y; Felts S; Toft DO; Neckers LM; Sharma SV
    Mol Endocrinol; 1999 Sep; 13(9):1435-48. PubMed ID: 10478836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel macrocyclic 2-amino-6-arylpyrimidine Hsp90 inhibitors.
    Suda A; Koyano H; Hayase T; Hada K; Kawasaki K; Komiyama S; Hasegawa K; Fukami TA; Sato S; Miura T; Ono N; Yamazaki T; Saitoh R; Shimma N; Shiratori Y; Tsukuda T
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1136-41. PubMed ID: 22192591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New, non-quinone fluorogeldanamycin derivatives strongly inhibit Hsp90.
    Hermane J; Bułyszko I; Eichner S; Sasse F; Collisi W; Poso A; Schax E; Walter JG; Scheper T; Kock K; Herrmann C; Aliuos P; Reuter G; Zeilinger C; Kirschning A
    Chembiochem; 2015 Jan; 16(2):302-11. PubMed ID: 25572106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geldanamycin derivative inhibition of HGF/SF-mediated Met tyrosine kinase receptor-dependent urokinase-plasminogen activation.
    Shen Y; Xie Q; Norberg M; Sausville E; Vande Woude G; Wenkert D
    Bioorg Med Chem; 2005 Aug; 13(16):4960-71. PubMed ID: 15978816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances in antitumor activity of the hsp90 inhibitor geldanamycin].
    Liao ZY; Zhen YS
    Yao Xue Xue Bao; 2001 Sep; 36(9):716-20. PubMed ID: 12580116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.